Evolving management of ST-segment elevation myocardial infarction: update on recent data.
1Thrombolysis in Myocardial Infarction (TIMI) Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA. cpcannon@partners.org
The American Journal of Cardiology
|December 16, 2006
Summary
New guidelines for ST-segment elevation myocardial infarction (STEMI) emphasize updated antithrombotic strategies. These include lower aspirin and unfractionated heparin doses, with clopidogrel showing improved outcomes.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Recent advancements in ST-segment elevation myocardial infarction (STEMI) management necessitate guideline updates.
- The American College of Cardiology (ACC) and American Heart Association (AHA) have revised acute myocardial infarction (MI) guidelines.
Purpose of the Study:
- To summarize the updated ACC/AHA recommendations for STEMI management.
- To highlight key changes in antithrombotic therapy strategies.
Main Methods:
- Review of recent clinical trials and findings on antithrombotic agents.
- Analysis of new recommendations for STEMI treatment.
Main Results:
- Shift towards lower long-term aspirin and unfractionated heparin (UFH) doses.
- Enoxaparin and fondaparinux evaluated as heparin alternatives.
- Support for early glycoprotein IIb/IIIa inhibitor use with aspirin, UFH, and clopidogrel in primary percutaneous coronary intervention (PCI).
- Clopidogrel demonstrated improved outcomes in STEMI patients undergoing thrombolysis or medical therapy.
Conclusions:
- New ACC/AHA guidelines advocate for updated antithrombotic strategies in STEMI.
- Clopidogrel pretreatment and long-term therapy are recommended for STEMI patients.
Related Concept Videos
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:22Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...